TY - JOUR
T1 - Glycated Hemoglobin and Risk of Arterial Stiffness in a Chinese Han Population
T2 - A Longitudinal Study
AU - Han, Ze
AU - Kang, Xiaoping
AU - Zhang, Jie
AU - Wang, Jinqi
AU - Liu, Yue
AU - Liu, Jia
AU - Wu, Zhiyuan
AU - Li, Xia
AU - Zhao, Xiaoyu
AU - Guo, Xiuhua
AU - Chen, Shuo
AU - Tao, Lixin
N1 - Publisher Copyright:
Copyright © 2022 Han, Kang, Zhang, Wang, Liu, Liu, Wu, Li, Zhao, Guo, Chen and Tao.
PY - 2022/4/29
Y1 - 2022/4/29
N2 - Background and Aims: Glycated hemoglobin (HbA1c) associates with the risk of arterial stiffness, and such association can be found between fasting blood glucose (FBG), postprandial blood glucose (PBG), triglyceride-glucose index (TyG index), and arterial stiffness. However, the results were inconsistent, longitudinal studies were sparse, and comparison of these glycemic parameters was less conducted. We aimed to explore the longitudinal relationship between HbA1c and arterial stiffness and compare the effect of the parameters. Methods: Data were collected from 2011 to 2019 in Beijing Health Management Cohort (BHMC) study. Cox proportional hazard models were fitted to investigate the association between the parameters and arterial stiffness. A generalized estimation equation (GEE) analysis was conducted to investigate the effect of repeated measurements of glycemic parameters. A receiver operating characteristic (ROC) analysis was performed to compare the predictive value of glycemic parameters for arterial stiffness. Results: Among 3,048 subjects, 591 were diagnosed as arterial stiffness during the follow-up. The adjusted hazard ratio (HR) [95% confidence interval (CI)] for arterial stiffness of the highest quartile group of HbA1c was 1.63 (1.22–2.18), which was higher than those of FBG, PBG, and TyG index. The nonlinear association of arterial stiffness with HbA1c and PBG was proved. The robust results of the sensitivity analysis were obtained. Conclusions: HbA1c is an important risk factor of arterial stiffness compared with PBG, FBG, and TyG index, and has a strong predictive ability for arterial stiffness among non-diabetics and the general population.
AB - Background and Aims: Glycated hemoglobin (HbA1c) associates with the risk of arterial stiffness, and such association can be found between fasting blood glucose (FBG), postprandial blood glucose (PBG), triglyceride-glucose index (TyG index), and arterial stiffness. However, the results were inconsistent, longitudinal studies were sparse, and comparison of these glycemic parameters was less conducted. We aimed to explore the longitudinal relationship between HbA1c and arterial stiffness and compare the effect of the parameters. Methods: Data were collected from 2011 to 2019 in Beijing Health Management Cohort (BHMC) study. Cox proportional hazard models were fitted to investigate the association between the parameters and arterial stiffness. A generalized estimation equation (GEE) analysis was conducted to investigate the effect of repeated measurements of glycemic parameters. A receiver operating characteristic (ROC) analysis was performed to compare the predictive value of glycemic parameters for arterial stiffness. Results: Among 3,048 subjects, 591 were diagnosed as arterial stiffness during the follow-up. The adjusted hazard ratio (HR) [95% confidence interval (CI)] for arterial stiffness of the highest quartile group of HbA1c was 1.63 (1.22–2.18), which was higher than those of FBG, PBG, and TyG index. The nonlinear association of arterial stiffness with HbA1c and PBG was proved. The robust results of the sensitivity analysis were obtained. Conclusions: HbA1c is an important risk factor of arterial stiffness compared with PBG, FBG, and TyG index, and has a strong predictive ability for arterial stiffness among non-diabetics and the general population.
KW - ankle brachial index
KW - arterial stiffness
KW - brachial-ankle pulse wave velocity
KW - glycated hemoglobin
KW - longitudinal study
UR - http://www.scopus.com/inward/record.url?scp=85130274036&partnerID=8YFLogxK
U2 - 10.3389/fendo.2022.854875
DO - 10.3389/fendo.2022.854875
M3 - Article
AN - SCOPUS:85130274036
SN - 1664-2392
VL - 13
SP - 854875
JO - Frontiers in Endocrinology
JF - Frontiers in Endocrinology
M1 - 854875
ER -